EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

With COVID-19 infections on the rise in the United States, people exhibiting respiratory symptoms are more likely to seek a test. Now that the disease is in its endemic stage, testing looks different ...

In a study involving nearly 1,000 patients seen at a Baltimore field hospital during a five-month period in 2022, researchers at Johns Hopkins Medicine, the University of Maryland School of Medicine, ...

As we get into another winter holiday season, COVID is still part of our lives. And although it's hard to predict exactly what this year's cold, flu and coronavirus season will look like, experts want ...

Q: When discussing the quick antibody tests, can you explain the difference between IgM and IgG antibodies? A: Immunoglobulin M (IgM) is the first antibody the body produces when it encounters a ...

We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...